The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients

Clinical trial NCT06649773 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06649773
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-10-25
Primary completion: 2025-05-28
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.